Merck to onshore cancer drug Keytruda in Wilmington
The future Merck Wilmington Biotech site will manufacture the cancer drug Keytruda for the U.S. as well as other innovative drugs. The post Merck to onshore cancer drug Keytruda in Wilmington appeared first on Delaware Business Times.